Literature DB >> 23436736

Glial-cell-mediated re-induction of the blood-brain barrier phenotype in brain capillary endothelial cells: a differential gel electrophoresis study.

Barbara Deracinois1, Gwënaël Pottiez, Philippe Chafey, Tom Teerlink, Luc Camoin, Mariska Davids, Cédric Broussard, Pierre-Olivier Couraud, Marie-Pierre Dehouck, Roméo Cecchelli, Yannis Karamanos, Christophe Flahaut.   

Abstract

In the neurovascular unit, brain microvascular endothelial cells develop characteristic barrier features that control the molecular exchanges between the blood and the brain. These characteristics are partially or totally lost when the cells are isolated for use in in vitro blood-brain barrier (BBB) models. Hence, the re-induction of barrier properties is crucial for the relevance of BBB models. Although the role of astrocyte promiscuity is well established, the molecular mechanisms of re-induction remain largely unknown. Here, we used a DIGE-based proteomics approach to study endothelial cellular proteins showing significant quantitative variations after BBB re-induction. We confirm that quantitative changes mainly concern proteins involved in cell structure and motility. Furthermore, we describe the possible involvement of the asymmetric dimethylarginine pathway in the BBB phenotype re-induction process and we discuss asymmetric dimethylarginine's potential role in regulating endothelial function (in addition to its role as a by-product of protein modification). Our results also suggest that the intracellular redox potential is lower in the in vitro brain capillary endothelial cells displaying re-induced BBB functions than in cells with limited BBB functions.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436736     DOI: 10.1002/pmic.201200166

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

Review 1.  Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells.

Authors:  Hannah K Wilson; Scott G Canfield; Eric V Shusta; Sean P Palecek
Journal:  Stem Cells       Date:  2014-12       Impact factor: 6.277

2.  A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors.

Authors:  Hui Xu; Zhongyu Li; Yue Yu; Saman Sizdahkhani; Winson S Ho; Fangchao Yin; Li Wang; Guoli Zhu; Min Zhang; Lei Jiang; Zhengping Zhuang; Jianhua Qin
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

3.  Cerebrovascular Pathology in Hypertriglyceridemic APOB-100 Transgenic Mice.

Authors:  Zsófia Hoyk; Melinda E Tóth; Nikolett Lénárt; Dóra Nagy; Brigitta Dukay; Alexandra Csefová; Ágnes Zvara; György Seprényi; András Kincses; Fruzsina R Walter; Szilvia Veszelka; Judit Vígh; Beáta Barabási; András Harazin; Ágnes Kittel; László G Puskás; Botond Penke; László Vígh; Mária A Deli; Miklós Sántha
Journal:  Front Cell Neurosci       Date:  2018-10-25       Impact factor: 5.505

4.  Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport.

Authors:  Yves Molino; Françoise Jabès; Emmanuelle Lacassagne; Nicolas Gaudin; Michel Khrestchatisky
Journal:  J Vis Exp       Date:  2014-06-28       Impact factor: 1.355

5.  P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.

Authors:  Qian Liu; Jinfeng Hou; Xiaoguang Chen; Gengtao Liu; Dan Zhang; Hua Sun; Jinlan Zhang
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.